Renvex Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Sevelamer carbonate

Indications/Uses

Control of serum P in adult & childn ≥6 yr w/ CKD on dialysis.

Click to view Renvex detailed prescribing information

Dosage/Direction for Use

Adults not taking phosphate binder w/ serum P ≥7.5 mg/dL 1.6 g tid; >5.5 & <7.5 mg/dL 0.8 g tid. Dose may be titrated by 0.8 g tid at 2-wk intervals. Childn ≥6 yr not taking phosphate binder w/ BSA ≥0.75-<1.2 m² 0.8 g-1.6 g tid titrate by 0.4-0.8 g. Dialysis patients switching from Ca acetate (667 mg) to sevelamer carbonate 0.8-2.4 g.

Click to view Renvex detailed prescribing information

Overdosage

View Renvex overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food.

Contraindications

Patients w/ hypophosphatemia or bowel obstruction.

Click to view Renvex detailed prescribing information

Special Precautions

Patients w/ dysphagia, swallowing disorders, severe GI motility disorders including severe constipation, or major GI tract surgery. Monitor bicarbonate & Cl levels; reduced vit D, E, K (clotting factors) & folic acid levels.

Click to view Renvex detailed prescribing information

Adverse Reactions

Vomiting, nausea, diarrhea, dyspepsia, abdominal pain, flatulence & constipation.

Click to view Renvex detailed prescribing information

Drug Interactions

Decreased bioavailability of ciprofloxacin.

Click to view Renvex detailed prescribing information

Storage

View Renvex storage conditions for details to ensure optimal shelf-life.

Description

View Renvex description for details of the chemical structure and excipients (inactive components).

Action

View Renvex mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antidotes & Detoxifying Agents

ATC Classification

V03AE02 - sevelamer ; Belongs to the class of drugs used in the treatment of hyperkalemia and hyperphosphatemia.

Regulatory Classification

Presentation/Packing

Form

Renvex FC tab 800 mg

Packing/Price

30's

Renvex

sevelamer

Manufacturer:

Haimen

Distributor:

Pharmabest